News
- Author:
- Will Pass
Publish date: April 15, 2019
GENEVA – Although NTRK fusions are relatively infrequent in lung cancer, a subgroup analysis demonstrates an overall ...
News
- Author:
- Will Pass
Publish date: April 12, 2019
GENEVA – Investigators analyzed data from 264 patients 75 years or older involved in the KEYNOTE-010, KEYNOTE-024, an...
News
- Author:
- Will Pass
Publish date: April 12, 2019
GENEVA - Patients with malignant pleural mesothelioma who were treated with TTFields in combination with pemetrexed and cisp...
News
- Author:
- Will Pass
Publish date: April 11, 2019
GENEVA – Radiogenomic MRI signatures may be useful in identifying ALK-positive brain metastases in NSCLC, allowing fo...
News
- Author:
- Will Pass
Publish date: April 11, 2019
GENEVA – For lung lesion biopsy, electromagnetic navigation bronchoscopy offers high navigational success with a relatively low rate of pneumothora...
News
- Author:
- Will Pass
Publish date: April 8, 2019
In contrast, developing type 2 diabetes over the age of 80 years had little impact on risk.
News
- Author:
- Will Pass
Publish date: April 7, 2019
GLASGOW – This research could guide the development of treatment strategies for hundreds of thousands of patients each year, particularly children....
News
- Author:
- Will Pass
Publish date: April 5, 2019
GLASGOW – The combination outperformed previously published data for other treatments in the relapsed/refractory setting.
News
- Author:
- Will Pass
Publish date: April 4, 2019
In a retrospective cost analysis of cancer-related inpatient visits among patients 65 or older, the top 10% of hospital visits were almost five tim...
News
- Author:
- Will Pass
Publish date: April 4, 2019
GLASGOW – Median progression-free survival was more than 20 months in real-world patients who received triplet therapy, similar to findings from th...
News
- Author:
- Will Pass
Publish date: April 4, 2019
GLASGOW – A study comparing whole-genome sequencing (WGS) with fluorescence in situ hybridization showed that the WGS was reliable and clinically r...
News
- Author:
- Will Pass
Publish date: March 26, 2019
In patients with endometrial cancer at high risk of progression, 5-year overall survival was 82.7% for doxorubicin/cisplatin, 86.1% for paclitaxel/...
News
- Author:
- Will Pass
Publish date: March 25, 2019
Sixteen years of data showed that daily aspirin therapy reduced the risk of HBV-related hepatocellular carcinoma by 29%.
News
- Author:
- Will Pass
Publish date: March 25, 2019
Review of 54 papers for gabapentin and 30 for pregabalin finds little evidence for effective pain control in off-label uses.
News
- Author:
- Will Pass
Publish date: March 22, 2019
The triplet combination of rituximab plus combination high-dose methotrexate and temozolomide could be a safe and effective first-line option for p...
